Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
iSTAR Medical
The study aims to assess long-term safety and performance of MINIject glaucoma implant up to 5 years post-implantation. Patients who received implant and were followed for 2 years in a previous study, will be invited to continue long-term follow-up from 2 to 5 years post-implantation at annual intervals. Standard ophthalmologic assessments including measurement of intraocular pressure, fundus examination, ocular imaging, assessment of any untoward ocular events etc. will be performed.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient who received a MINIject glaucoma implant within a prior clinical study
Patient continues to have MINIject implanted at the point of enrolment
Patient must provide written informed consent to participate
You may not be if
Individuals under tutorship or trusteeship
Patient who is unwilling to return to the study visits and undergo study assessments, as required by clinical study protocol